Erratum to: Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer

被引：0
|
作者：
Carlos Caicedo
Maria Jose Garcia-Velloso
Maria Dolores Lozano
Tania Labiano
Carmen Vigil-Diaz
Jose Maria Lopez-Picazo
Alfonso Gurpide
Javier J. Zulueta
Jose Angel Richter-Echevarria
Jose Luis Perez-Gracia
机构：
[1] University of Navarra,Nuclear Medicine Department, University Clinic of Navarra
[2] University of Navarra,Pathology Department, University Clinic of Navarra
[3] University of Navarra,Oncology Department, University Clinic of Navarra
[4] University of Navarra,Pulmonology Department, University Clinic of Navarra
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2164 / 2164
相关论文
共 50 条
  • [31] The diagnostic and predictive efficacy of 18F-FDG PET/CT metabolic parameters for EGFR mutation status in non-small-cell lung cancer: A meta-analysis
    Guo, Yue
    Zhu, Hui
    Yao, Zhiming
    Liu, Fugeng
    Yang, Dawei
    EUROPEAN JOURNAL OF RADIOLOGY, 2021, 141
  • [32] Customized Chemotherapy on the Basis of EGFR Mutation Status for Elderly Patients With Advanced Non-Small-Cell Lung Cancer
    Kunimasa, K.
    Katakami, N.
    Masago, K.
    Yoshioka, H.
    Tomii, K.
    Kaneda, T.
    Hirabayashi, M.
    Morizane, T.
    Fujita, S.
    Mio, T.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S280 - S280
  • [33] The Role of 18F FDG PET-CT in Staging and Outcome Prediction for Small Cell Lung Cancer (SCLC)
    McKay, S.
    Han, S.
    Mohammed, N.
    Tho, L. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S570 - S570
  • [34] 18F-FDG UPTAKE PREDICTS THE PRESENCE OF EGFR MUTATIONS IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER
    Na, I. I.
    Byun, B. H.
    Kim, K. M.
    Cheon, G. J.
    Choe, D. H.
    Koh, J. S.
    Ryoo, B.
    Yang, S. H.
    Kim, C. H.
    Lee, J. C.
    ANNALS OF ONCOLOGY, 2008, 19 : 112 - 112
  • [35] Clinical Impact of [18F]FDG PET-CT in the Staging of Stage III Non-Small-Cell Lung Cancer
    Alvarez Mena, N.
    Sebastian Palacid, F.
    Zambrano Infantino, R.
    Jaramillo Lopez, B.
    Garcia Aragon, M.
    Ruano Perez, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S495 - S495
  • [36] [18F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab
    Valentinuzzi, Damijan
    Vrankar, Martina
    Boc, Nina
    Ahac, Valentina
    Zupancic, Ziga
    Unk, Mojca
    Skalic, Katja
    Zagar, Ivana
    Studen, Andrej
    Simoncic, Urban
    Eickhoff, Jens
    Jeraj, Robert
    RADIOLOGY AND ONCOLOGY, 2020, 54 (03) : 285 - 294
  • [37] Association of 18F-FDG uptake in PET/CT and KRAS mutation in advanced lung cancer
    Garcia-Velloso, Maria J.
    Caicedo, Carlos
    Lozano, Maria
    Vigil, Carmen
    Labiano, Tania
    Gonzalez-Forero, Maria
    Perez-Gracia, Jose L.
    Seijo, Luis
    Rodriguez, Macarena
    Richter, Jose
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [38] Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non-Small-Cell Lung Cancer
    Bai, Hua
    Wang, Zhijie
    Chen, Keneng
    Zhao, Jun
    Lee, J. Jack
    Wang, Shuhang
    Zhou, Qinghua
    Zhuo, Minglei
    Mao, Li
    An, Tongtong
    Duan, Jianchun
    Yang, Lu
    Wu, Meina
    Liang, Zhen
    Wang, Yuyan
    Kang, Xiaozheng
    Wang, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) : 3077 - 3083
  • [39] Performance of 18F-FDG PET/MRI and 18F-FDG PET/CT for T and N staging in patients with non-small-cell lung cancer
    Laffon, Eric
    Marthan, Roger
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (02) : 522 - 523
  • [40] Performance of 18F-FDG PET/MRI and 18F-FDG PET/CT for T and N staging in patients with non-small-cell lung cancer
    Eric Laffon
    Roger Marthan
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 522 - 523
12345